Orally taken medicine for treating qi stagnation and blood stasis syndrome after thyroid cancer operation and preparation method thereof

A technology for qi stagnation and blood stasis syndrome and thyroid cancer, which is applied in drug combinations, pharmaceutical formulations, medical preparations containing active ingredients, etc., can solve problems such as difficulty in returning to normal and affect the quality of life of patients, and achieve good results.

Inactive Publication Date: 2017-12-15
CHENGDU XINGBEIJIA BIOTECH CO LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Western medicine has also brought certain adverse reactions when implementing radical thyroid cancer surgery, such as: after the treatment of the disease, the hematopoietic function of the bone marrow is inhibited, causing a decrease in white blood cells, hemoglobin, and platelets, and it is difficult to return to normal in a short time; Fatigue, swelling, numbness, and tingling in the neck and shoulders; emotional changes after thyroid hormone suppression therapy, palpitation and chest tightness, etc., seriously affected the quality of life of the patient

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] An oral medicine for the treatment of Qi stagnation and blood stasis syndrome after thyroid cancer surgery, characterized in that the components of the medicine and their mass parts are as follows:

[0038]Crow 360g, Bupleurum 70g, Milk Chai 720g, Xia Wu 115g, Agrimony 115g, Qingpi 80g, Curcuma 95g, Calla lily 200g, Shanzi mushroom 80g, Chuanxiong 95g, Dieda Lao 115g, Convolvulus root 118g, Cyperus cyperi 80g, roasted licorice 95g, Prunella vulgaris 115g, auxiliary materials: micropowder silica gel, microcrystalline cellulose and appropriate amount of starch.

Embodiment 2

[0040] An oral medicine for the treatment of Qi stagnation and blood stasis syndrome after thyroid cancer surgery, characterized in that the components of the medicine and their mass parts are as follows:

[0041] Crow 420g, Bupleurum 80g, Milk Chai 850g, Xiawu 130g, Agrimony 130g, Qingpi 90g, Curcuma 105g, Calla lily 220g, Shanzi mushroom 90g, Chuanxiong 105g, Dieda Lao 130g, Convolvulus root 130g, Cyperus cyperi 90g, roasted licorice 105g, Prunella vulgaris 130g, auxiliary materials: micropowder silica gel, microcrystalline cellulose and appropriate amount of starch.

Embodiment 3

[0043] An oral medicine for the treatment of Qi stagnation and blood stasis syndrome after thyroid cancer surgery, characterized in that the components of the medicine and their mass parts are as follows:

[0044] Crow 500g, Bupleurum 90g, Milk Chai 1000g, Xiawu 150g, Agrimony 150g, Qingpi 100g, Curcuma 120g, Calla lily 250g, Shanzi mushroom 100g, Chuanxiong 120g, Dieda Lao 150g, Convolvulus root 160g, Cyperus cyperi 100g, roasted licorice 120g, Prunella vulgaris 160g, auxiliary materials: micropowder silica gel, microcrystalline cellulose and appropriate amount of starch.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of traditional Chinese medicinal preparations and aims at providing an orally taken medicine for treating qi stagnation and blood stasis syndrome after a thyroid cancer operation. The orally taken medicine comprises the following components in parts by weight: 250-500g of Japanese angelica tree root bark, 30-90g of radix bupleuri, 500-1000g of ficus lyrata, 60-150g of corydalis amabilis, 60-150g of hairyvein agrimony, 30-100g of pericarpium citri reticulatae viride, 30-120g of curcuma zedoary, 150-250g of alocasia, 30-100g of edible tulip, 30-120g of ligusticum wallichii, 50-150g of whorled litsea, 100-160g of scammoniae radix, 60-100g of rhizoma cyperi, 30-120g of honey-fried liquorice root and 90-160g of selfheal. The orally taken medicine provided by the invention is a good traditional Chinese medicinal composition.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine preparations, and in particular relates to an oral medicine for treating thyroid cancer postoperative qi stagnation and blood stasis syndrome, in particular to the field of an oral medicine for patients with thyroid cancer postoperative qi stagnation and blood stasis syndrome and a preparation method. Background technique [0002] The motherland medicine thinks: Thyroid cancer, thyroid cancer is a kind of clinical common malignant tumor of the neck, and the incidence rate is showing the trend of rising year by year in our country. Currently in the Chinese population, the prevalence of thyroid nodules is 18.6%, of which malignant nodules (ie, thyroid cancer) account for 5% to 10%, and the pathological types are mainly divided into papillary carcinoma, follicular carcinoma, and undifferentiated carcinoma. , Medullary carcinoma, etc. In addition to the development and improvement of diagn...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9066A61K9/48A61P35/00A61P35/04
CPCA61K36/25A61K9/4866A61K36/233A61K36/236A61K36/39A61K36/484A61K36/536A61K36/54A61K36/60A61K36/66A61K36/73A61K36/752A61K36/888A61K36/8905A61K36/898A61K36/9066A61K2236/331A61K2236/39A61K2236/51A61K2300/00
Inventor 罗兴贵
Owner CHENGDU XINGBEIJIA BIOTECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap